Should the federal government provide tax incentives to companies to encourage them to conduct clinical trials in the U.S. rather than in other countries?
2017Q2 | 2014Q2 | |
---|---|---|
Yes | 52.6% | 49.1% |
No | 19.4% | 23.6% |
Not sure | 28.0% | 27.3% |
["Yes","No","Not sure"]
[{"label":"2017Q2","data":["52.6","19.4","28.0"]},{"label":"2014Q2","data":["49.1","23.6","27.3"]}]